GenVec, Inc. is a biopharmaceutical company developing pharmaceuticals and vaccines based on novel biotechnology such as targeted delivery systems. The company has a number of drugs currently in various phases of clinical trials. Its lead product candidate is TNFerade(TM), being developed for the treatment of solid tumors. The company has been contracted by the United State's Department of Homeland Security to develop a vaccine for Foot-and-mouth disease.
GenVec signs contract for preventative AIDS vaccine.(3-year contract has estimated value of $10.2 mn)(Government Activity)(Product Development)(Brief Article)
Feb 01, 2002; GenVec, Inc. (Gaithersburg, MD; 240-632-5533) announced that it has signed a contract with the Vaccine Research Center at...